Marshall Wace North America L.P. - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 201 filers reported holding CANTEL MEDICAL CORP in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$7,259,000
+309.4%
90,890
+304.5%
0.03%
+275.0%
Q4 2020$1,773,000
+4.5%
22,471
-41.8%
0.01%
-27.3%
Q3 2020$1,696,000
+1325.2%
38,617
+1067.4%
0.01%
+1000.0%
Q1 2020$119,000
-13.1%
3,308
+80.6%
0.00%0.0%
Q3 2019$137,000
-41.5%
1,832
-36.8%
0.00%0.0%
Q2 2019$234,000
+207.9%
2,900
+157.1%
0.00%
Q1 2019$76,000
-95.4%
1,128
-94.9%
0.00%
-100.0%
Q4 2018$1,641,000
+39.3%
22,045
+72.4%
0.02%
+300.0%
Q3 2018$1,178,000
+3.3%
12,788
+24.9%
0.00%
-33.3%
Q1 2018$1,140,000
-75.5%
10,236
-82.9%
0.01%
-82.4%
Q2 2017$4,656,000
+73.6%
59,696
+78.1%
0.03%
+61.9%
Q1 2017$2,682,00033,5250.02%
Other shareholders
CANTEL MEDICAL CORP shareholders Q3 2020
NameSharesValueWeighting ↓
DIKER MANAGEMENT LLC 1,805,250$61,144,00018.90%
Brown Capital Management 4,069,141$137,822,0002.95%
Kimelman & Baird, LLC 364,514$12,346,0002.60%
Teton Advisors, Inc. 396,782$13,439,0001.18%
Ranger Investment Management 565,995$19,170,0000.93%
Geller Advisors LLC 26,043$882,0000.75%
CONNORS INVESTOR SERVICES INC 57,826$1,959,0000.63%
Boston Trust Walden Corp 733,798$24,853,0000.40%
MISSOURI VALLEY PARTNERS, INC. 24,481$829,0000.32%
GENEVA CAPITAL MANAGEMENT LLC 451,958$15,307,0000.31%
View complete list of CANTEL MEDICAL CORP shareholders